Stories from MedEsthetics
Thursday, September 28, 2017 - 14:31
The number of surgical hair restoration procedures performed worldwide increased by 60% from 2014 to 2016 with 635,189 procedures performed last year, according to the results of the International Society of Hair Restoration Surgery (ISHRS) Practice Census Survey. Of the 635,189 procedures performed, Asia led the way with 195,284 procedures, followed by the Middle East with 149,400 and the U.S. with 133,136 procedures. The number of nonsurgical hair restoration patients also increased considerably with 1,241,764 nonsurgical patients treated in 2016 (a 78% increase from 2014).
Thursday, September 28, 2017 - 14:30
Cynosure’s SculpSure noninvasive body contouring laser system (now owned by Hologic) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the treatment of submental fat. The device was previously cleared to treat the abdomen, flanks, back and inner and outer thighs.
Thursday, September 21, 2017 - 10:54
The United States Food and Drug Administration (FDA) has approved a cross-linked hyaluronic acid dermal filler from Ontario, Canada-based Prollenium Medical Technologies. The soft tissue filler is sold under the brand Revanesse in Canada. At the time of print, Prollenium had not announced a brand name or date of commercial availability in the U.S.
Thursday, September 21, 2017 - 10:51
A split-lip study, published in Aesthetic Surgery (October 2017) has revealed that vibration can reduce the pain of filler injections during lip augmentation. Authors Kirdar Guney, MD, Billur Sezgin, MD, and Reha Yavuzer, MD, used vibration stimulus on 25 patients undergoing lip augmentation with a hyaluronic acid filler. Patients were asked to score the pain during treatment on a scale of 0 to 10 (0 being no pain and 10 the worst pain they had ever felt) for each half of their lips.
Thursday, September 21, 2017 - 10:47
Dermatologist Michael H. Gold, MD, has joined the Scientific Advisory Board of AIVITA Biomedical, a clinical research company and commercial skincare product developer. He joins other notable skincare professionals including: Mary Lupo, MD, founder of the Lupo Center for Aesthetic and General Dermatology; Zoe Draelos, MD, research and clinical dermatologist; and consumer skincare industry veteran Susan Bloomfield in this role. Dr. Gold’s addition comes as AIVITA prepares to launch its upcoming ROOT OF SKIN line of rejuvenating skincare products.
Thursday, September 21, 2017 - 10:44
Creating a culture of safety requires more than by the book adherence to OSHA standards— and pays dividends in employee satisfaction and patient outcomes.By Shelley Moench-Kelly, MBAMedical practices place significant emphasis on patient safety and outcomes. But without equal attention to employee safety, patient care can suffer. Low morale, staffing shortages due to injury and the potential for costly fines are just some of the ways a lack of attention to workplace safety can undermine your aesthetic business. Following is an overview of the workplace safety regulatory requirements for...
Thursday, September 14, 2017 - 12:35
Before-and-after images are one of the most effective patient satisfaction and marketing tools available to aesthetic practices. But the quality of your photos is key to reaping the benefits. Different backgrounds, varying hairstyles, and changes in patient positioning may raise red flags for savvy patients, while poor lighting can detract from the outcomes you are trying to highlight.
Thursday, September 14, 2017 - 12:32
Allergan has updated it Brilliant Distinctions patient reward program with new digital tools and new qualifying services. Patients can now earn rewards for CoolSculpting treatments in addition to Botox Cosmetic and Juvederm procedures, Skinmedica products and Latisse purchases. They can also purchase Skinmedica products online through the new Brilliant Connection e-commerce site.
Thursday, September 14, 2017 - 12:29
Breast implant manufacturers Allergan and Sientra have each made financial contributions to the American Society for Aesthetic Plastic Surgery (ASAPS) to help fund the development of software that will enable ASAPS to acquire data on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). The technology will enable both the organization and the industry to garner data and improve outcomes directly at the point-of-care, via ASAPS member practices.
Thursday, September 14, 2017 - 12:18
George J. Hruza, MD, immerses himself in the dermatology community to ensure a stronger specialty and take advantage of lifelong learning opportunities.By Keith LoriaGeorge J. Hruza, MD, has always been surrounded by the medical field. His mother was a pediatrician, who later became a psychiatrist. His father was a gerontology researcher and pathologist. His sister is a radiologist; her husband is a rheumatologist. So it’s no surprise that Dr. Hruza, founder of the Laser & Dermatologic Surgery Center in Chesterfield, Missouri, also sought a career in medicine. “It seemed like a profession...
Thursday, September 7, 2017 - 11:56
In a statement released on August 28, 2017, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, outlined the agency’s new policy goals and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine. His statement reads in part:
Thursday, September 7, 2017 - 11:53
Alisa Lask is the new vice president and general manager of Galderma’s Aesthetic & Corrective Business unit in the U.S. Chris Chapman has been named vice president and general manager of the company’s Prescription Business unit in the U.S.
Thursday, September 7, 2017 - 11:46
Aesthetic practitioners offering minimally invasive injectable treatments for rejuvenation of the lower third of the face should start with soft-tissue fillers to provide structure and support before considering botulinum toxins to reduce fine lines, according to an article by Mauricio de Maio, MD, et al, published in Plastic and Reconstructive Surgery (September 2017). Treatment recommendations offered by the authors of “Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face” include:
Thursday, September 7, 2017 - 11:44
Microdroplet injections of low-viscosity hyaluronic acid-based fillers are gaining fans around the globe.By Inga HansenHydrating fillers—low-viscosity hyaluronic acid-based materials injected superficially throughout the face to improve skin tone—have become popular offerings outside of the U.S. and are finding their way onto aesthetic message boards and review sites, generating significant interest among U.S.-based consumers. Outside the states, physicians have access to specifically formulated products, such as Juvéderm Hydrate, Restylane Vital and Restylane Vital Light, as well as robust...
Monday, August 28, 2017 - 12:04
FEATURES The most buzzworthy new antiaging actives »Cutting-Edge Ingredients
Thursday, August 24, 2017 - 09:47
A closer look at some of the most buzzworthy new ingredients in antiaging skin care.By Inga HansenNew products that promise to “unlock a more youthful appearance,” “turn back the hands of time,” and “reset the aging process” bombard consumers and skincare professionals on a seemingly daily basis. While we know that topical skincare is vital to skin health, the question is, do these new ingredients deserve a space on your retail shelves?
Thursday, August 24, 2017 - 09:36
Patients with cellulite and skin laxity who underwent treatment with microfocused ultrasound with visualization (MFU-V; Ultherapy) in combination with diluted calcium hydroxylapatite (CaHa; Radiesse) saw a significant improvement in laxity and a significant reduction in dimpling. Gabriel Casabona, MD, and Gregorio Pereira, MD, published the results of their retrospective study of 20 female patients (mean age: 40.0 ± 8.2 years; mean BMI 21.5 ± 1.5 kg/m2) in Plastic and Reconstructive Surgery – Global Open (July 2017).
Thursday, August 24, 2017 - 09:33
Revance Therapeutics, a biotechnology company developing botulinum toxin products for aesthetic and therapeutic concerns has appointed Todd Zavodnick to chief commercial officer and president of its Aesthetics & Therapeutics division. Zavodnick will report to Revance’s CEO Dan Browne, and lead the company’s commercial operations along with the launch of its injectable daxibotulinumtoxinA (RT002).